MED-RIVASTIGMINE
GENERIC MEDICAL PARTNERS INC
Quick answers
Is there a shortage of MED-RIVASTIGMINE in Canada?
No. There is no current shortage of MED-RIVASTIGMINE 4.5MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
JAMP RIVASTIGMINE CAPSULES
JAMP PHARMA CORPORATION
Other Products
EXELON
KNIGHT THERAPEUTICS INC.
APO-RIVASTIGMINE
APOTEX INC
MED-RIVASTIGMINE
GENERIC MEDICAL PARTNERS INC
JAMP RIVASTIGMINE
JAMP PHARMA CORPORATION
DIN
02401630
Strength
4.5MG
Dosage Form
Capsule
Route
Oral
Active Ingredient
RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE)
See all RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from GENERIC MEDICAL PARTNERS INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
500MG · DIN 02524449
1MG · DIN 02494574
50MG · DIN 02501481
20MG · DIN 02452421
10MG · DIN 02480042
1000MG · DIN 02496925
0.2% · DIN 02507811
150MG · DIN 02462656
300MG · DIN 02462664
50MG · DIN 02390760
2% · DIN 02457210
DIN 02437686